Increased hepatic nicotinamide n-methyltransferase activity as a marker of cancer cachexia in mice bearing colon 26 adenocarcinoma

Japanese Journal of Cancer Research

Volumn 89, Issue 6, 1998, Pages 649-656

  Okamura, Atsushi ^a   Ohmura, Yoshihisa ^a   Islam, Md Muzharul ^a   Tagawa, Masatoshi ^a,c   Horitsu, Keisuke ^b   Moriyama, Yoichi ^a   Fujimura, Shinji ^a  

^a CHIBA UNIVERSITY   (Japan)

^b TOKYO KASEI UNIVERSITY   (Japan)

^c CHIBA CANCER CENTER   (Japan)

Author keywords

Cancer cachexia; Colon 26 adenocarcinoma; Liver; Nicotinamide N methyltransferase

Indexed keywords

DOXIFLURIDINE; FLUOROURACIL; NICOTINAMIDE METHYLTRANSFERASE; TEGAFUR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CACHEXIA; COLON ADENOCARCINOMA; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; WEIGHT REDUCTION;

EID: 0031844546     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1998.tb03267.x     Document Type: Article

References (48)

1. 14C]pyridine. Xenobiotica, 10, 151-157 (1980).
2. Seifert, R., Hoshino, J. and Kröger, H. Nicotinamide methylation. Tissue distribution, developmental and neoplastic changes. Biochim. Biophys. Acta, 801, 259-264 (1984).
3. Alton, T. A. and Abeles, R. H. Substrate specificity of nicotinamide methyltransferase isolated from porcine liver. Arch. Biochem. Biophys., 260, 601-608 (1988).
4. Aksoy, S., Szumlanski, C. L. and Weinshilboum, R. M. Human liver nicotinamide N-methyltransferase: cDNA cloning, expression and biochemical characterization. J. Biol. Chem., 265, 14835-14840 (1994).
5. Aksoy, S., Brandriff, B. F., Ward, A., Little, P. F. R. and Weinshilboum, R. M. Human nicotinamide N-methyltransferase gene: molecular cloning, structural characterization and chromosomal localization. Genomics, 29, 555-561 (1995).
6. Norton, J. A., Peacock, J. L. and Morrison, S. D. Cancer cachexia. Crit. Rev. Oncol./Hematol., 7, 289-327 (1987).
7. DeWys, W. D. Management of cancer cachexia. Semin. Oncol., 12, 452-460 (1985).
8. Hanazawa, Y., Kuroiwa, N., Ogawa, M., Moriyama, Y. and Fujimura, S. Characterization of nicotinamide methyltransferase in livers of mice bearing Ehrlich ascites tumors: preferential increase of activity. Tumor Biol., 15, 7-16 (1994).
9. Corbett, T. H., Griswold, D. P., Jr., Roberts, B. J., Peckham, J. C. and Schabel, F. M., Jr. Tumor induction relationships in development of transplantable cancers of the colon in mice for chemotherapy assays, with a note on carcinogen structure. Cancer Res., 35, 2434-2439 (1975).
10. Tanaka, Y., Eda, H., Tanaka, T., Udagawa, T., Ishikawa, T., Horii, I., Ishitsuka, H., Kataoka, T. and Taguchi, T. Experimental cancer cachexia induced by transplantable colon 26 adenocarcinoma. Cancer Res., 50, 2290-2295 (1990).
11. Strassmann, G., Fong, M., Kenney, J. S. and Jacob, C. O. Evidence for the involvement of interleukin 6 in experimental cancer cachexia. J. Clin. Invest.., 89, 1681-1684 (1992).
12. Ouchi, K. F.,Tamura, S.,Mori, K.,Tanaka, Y. and Ishitsuka, H. Establishment and characterization of cachexia-inducing and -non-inducing clones of murinc colon 26 carcinoma. Int. J. Cancer, 61, 522-528 (1995).
13. Tanaka, Y., Eda, H., Fujimoto, K., Tanaka, T., Ishtkawa, T. and Ishitsuka, H. Anticachectic activity of 5′-deoxy-5-fluorouridine in a murine tumor cachexia model, colon 26 adenocarcinoma. Cancer Res., 50, 4528-4532 (1990).
14. 1-Methylnicotinamide level in the blood after nicotinamide loading as further evidence for malignant tumor burden. Jpn. J. Cancer Res., 82, 1277-1283 (1992).
15. Lowry, O. H., Rosebrough, N. J., Farr, A. L. and Rundall, R. J. Protein measurement with the Folin phenol reagent. J. Biol. Chem., 193, 265-275 (1951).
16. Chirgwin, J. M., Przybyla, A. E., MacDonald, R. J. and Rutter, W. J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry, 18, 5294-5299,(1979).
17. Yasumoto, K., Mukaida, N., Harada, A., Kuno, K., Akiyama, M., Nakashima, E., Fujioka, N., Mai, M., Kasahara, T., Fujimoto-Ouchi, K., Mori, K., Tanaka, Y. and Matsushima, K. Molecular analysis of the cytokine network involved in cachexia in colon 26 adenocarcinomabearing mice. Cancer Res., 55. 921-927 (1995).
18. Robbins, S. L. In "Pathological Basis of Disease," pp.106-115 (1974). W. B. Saunders Co., Philadelphia.
19. Nathanson, L. and Hall, T. C. A spectrum of tumors that produce paraneoplastic syndromes. Lung tumors: how they produce their syndromes. Ann. NY Acad. Sci., 230, 367-377 (1974).
20. De Wys, W. D., Begg, C., Lavin, P. T., Band, P. R., Bennet, J. M., Bertino, J. R., Cohen, M. H., Douglass, H. O., Engstrom, P. F., Ezdinli, E. Z., Horton, J., Johnson, G. J., Moertel, C. G., Oken, M. M., Perlia, C., Rosenbaum, C., Silverstein, M. N., Skeel, R. T., Sponzo, R. W. and Tormey, D. C. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Am. J. Med., 69, 491-497 (1980).
21. De Wys, W. D., Begg, C., Band, P. and Tormey, D. The impact of malnutrition on treatment in breast cancer. Cancer Treat. Rep., 65 (Suppl. 5), 855-915 (1981).
22. Warnold, I., Lundholm, K. and Scherstein, T. Energy balance and body composition in cancer patients. Cancer Res., 38, 1801-1807 (1978).
23. Mori, K., Fujimoto-Ouchi, K., Ishikawa, T., Sekiguchi, F., Ishitsuka, H. and Tanaka, Y. Murine interleukin-12 prevents the development of cancer cachexia in a murine model. Int. J. Cancer, 67, 849-855 (1996).
24. Fujii, S., Yuasa, A., Kawachi, T., Okamura, Y., Wakasugi, H. and Yamamura, Y. Purification of toxohormone by carboxymethylcellulose column chromatography. Gunn, 55, 67-71 (1964).
25. Masuno, H., Yoshimura, H., Ogawa, N. and Okuda, H. Isolation of a lipolytic factor (toxohormone-L) from ascites fluid of patients with hepatoma and its effect on feeding behavior. Eur: J. Cancer Clin. Oncol., 20, 1177-1185 (1987).
26. Todorov, P., Cariuk, P., McDevitt, T., Coles, B., Fearon, K. and Tisdale, M. Characterization of a cancer cachectic factor. Nature, 379, 739-742 (1996).
27. Kitada, S., Hays, E. F. and Mead, J. F. Characterization of a lipid mobilizing factor from tumors. Prog. Lipid Res., 20, 823-826 (1981).
28. Taylor, D. D., Gercel-Taylor, C., Jenio, L. G. and Devereux, D. F. Identification of a human tumor-derived lipolysis-promoting factor. Cancer Res., 52, 829-834 (1992).
29. McDevitt, T. M., Todorov, P. T., Beck, S. A., Khan, S. H. and Tisdale, M. J. Purification and characterization of a lipid-mobilizing factor associated with cachexia-inducing tumors in mice and humans. Cancer Res., 55, 1458-1463 (1995).
30. Beutler, B. and Cerami, A. Cachectin and tumor necrosis factor as two sides of the same biological coin. Nature, 320, 584-588 (1986).
31. Matthys, P., Dijkmans, R., Proost, P., Van Damme, J., Heremans, H., Sobis, H. and Billiau, A. Severe cachexia in mice inoculated with interferon-gamma-producing tumor cells. Int. J. Cancer, 49, 77-82 (1991).
32. Mori, M., Yamaguchi, K., Honda, S., Nagasaki, K., Ueda, M., Abe, O. and Abe, K. Cancer cachexia syndrome developed in nude mice bearing melanoma cells producing leukemia-inhibitory factor. Cancer Res., 51, 6656-6659 (1991).
33. Zugmaier, G., Paiks, S., Wilding, G., Knabbe, C., Bano, M., Lupu, R., Deschauner, B., Simpson, S., Dickson, R. B. and Lippmann, M. Transforming growth factor β1 induces cachexia and systemic fibrosis without an antitumor effect in nude mice. Cancer Res., 51. 3590-3594 (1991).
34. Soda, K., Kawakami, M., Kashii, A. and Miyata, M. Characterization of mice bearing subclones of colon 26 adenocarcinoma disqualifies interleukin-6 as the sole inducer of cachexia. Jpn. J. Cancer Res., 85, 1124-1130 (1994).
35. Metcalf, D., Nicola, N. A. and Gearing, D. P. Effects of injected leukemia inhibitory factor on hematopoietic and other tissues in mice. Blood, 76, 50-56 (1990).
36. Socher, S. H., Martinetz, D., Craig, J. B., Kuhn, J. K. and Oliff, A. Tumor necrosis factor not detectable in patients with clinical cancer cachexia. J. Natl. Caner Inst., 80, 595-598 (1988).
37. Fujimura, S. and Shimizu, M. Enhanced activity of tRNA-pseudouridine synthetase in Yoshida ascites sarcoma. Biochem. Biophys. Res. Commun., 79, 763-768 (1977).
38. Shimizu, M. and Fujimura, S. Studies on the abnormal excretion of pyrimidine nucleosides in the urine of Yoshida ascites sarcoma-bearing rats. Increased excretion of deoxycytidine, pseudouridine and cytidine. Biochim. Biophys. Acta, 517, 277-286 (1978).
39. Shimizu, M. and Fujimura, S. Origin of increased deoxycytidine excretion into urine of rats bearing Yoshida ascites sarcoma. Cancer Res., 44, 2387-2392 (1984).
40. Asanagi, M., Moriyama, Y. and Fujimura, S. Purification and characterization of thymidylate synthetase in liver of the mouse bearing Ehrlich ascites tumor. Arch. Biochem. Biophys., 267, 749-757 (1988).
41. Tanaka, N., Sekiya, S., Takamizawa, H., Kato, N., Moriyama, Y. and Fujimura, S. Characterization of a 54 kDa, αl-antitrypsin-like protein isolated from ascitic fluid of an endometrial cancer patient. Jpn. J. Cancer Res., 82, 1277-1283 (1991).
42. Nakahara, W. and Fukuoka, F. Toxohormnones: a characteristic toxic substance produced by cancer tissue. Gann, 40, 45-69 (1949).
43. Ishitsuka, H., Miwa, M., Takemoto, K., Fukuoka, K., Itoga, A. and Maruyama, H. B. Role of uridine phosphorylase for antitumor activity of 5′-deoxy-5-fluorouridine. Gann, 71, 112-123 (1980).
44. Bollag, W. and Hartmann, H. R. Tumor inhibitory effects of a new fluorouracil derivative: 5′-dcoxy-5-fluorouridine. Eur. J. Cancer, 16, 427-432 (1980).
45. Eda, H., Fujimoto, K., Watanabe, S., Ishikawa, T., Ohiwa, T., Tatsuno, K., Tanaka, Y. and Ishitsuka, H. Cytokines induce uridine phosphorylase in mouse colon 26 carcinoma cells and make the cells more susceptible to 5′-deoxy-5-fluorouridine. Jpn. J. Cancer Res., 84, 341-347 (1993).
46. Eda, H., Fujimoto, K., Watanabe, S., Ura, M., Hino, A., Tanaka, Y., Wada, K. and Ishitsuka, H. Cytokines induce thymidine phosphorylase expression in tumor cells and make them more susceptible to 5′-deoxy-5-fluorouridine. Cancer Chemother. Pharmacol., 32, 333-338 (1993).
47. Strassmann, G., Masui, Y., Chizzonite, R. and Fong, M. Mechanisms of experimental cancer cachexia. Local involvement of IL-1 in colon-26 tumor. J. Immunol., 150, 2341-2345 (1993).
48. Fujimura, S., Kato, N., Han, J. Y., Hanazawa, Y., Nakagawa, K. and Horitsu, K. Increase of nicotinamide methyltransferase activity in the liver of the mouse after transplantation of Ehrlich ascites tumor. In "Advances in Tryptophan Research," pp.179-182 (1992). F. H. U. Press, Japan.